1. Home
  2. MCRB vs VWAV Comparison

MCRB vs VWAV Comparison

Compare MCRB & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seres Therapeutics Inc.

MCRB

Seres Therapeutics Inc.

HOLD

Current Price

$9.42

Market Cap

139.7M

Sector

Health Care

ML Signal

HOLD

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$6.76

Market Cap

148.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCRB
VWAV
Founded
2010
2024
Country
United States
United States
Employees
N/A
12
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
139.7M
148.1M
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
MCRB
VWAV
Price
$9.42
$6.76
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$14.33
N/A
AVG Volume (30 Days)
46.0K
251.0K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$789,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.28
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.36
$2.06
52 Week High
$29.98
$15.80

Technical Indicators

Market Signals
Indicator
MCRB
VWAV
Relative Strength Index (RSI) 43.72 36.95
Support Level $6.99 $6.77
Resistance Level $9.60 $10.36
Average True Range (ATR) 0.53 0.57
MACD 0.24 0.05
Stochastic Oscillator 77.57 7.50

Price Performance

Historical Comparison
MCRB
VWAV

About MCRB Seres Therapeutics Inc.

Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

Share on Social Networks: